Nothing said here yet.
to join the conversation.
Aegon (ENXTAM:AGN) continues to attract attention after recent share price swings, with the stock up 0.8% at the latest close even as the past month shows a decline of about 5%.
Aegon has delivered a strong 5 year share price run, which puts fresh focus on a simple question for anyone looking at the stock today: Is the current market value properly aligned with what the insurer actually earns?
This week of The Dealmaking 3 with “The Sports Professor” Rick Horrow features DoorDash, Inc. (Nasdaq: DASH) partnering with the Australian Open starting in 2027 and combining venue branding with food delivery at the Golden Hour Bar, AEG bringing…
Schiphol, October 15, 2026 - Aegon today announces that it has repurchased all outstanding Common Shares B held by its largest shareholder, Vereniging Aegon Americas, in exchange for common shares with equal voting rights on a 40-to-1 basis, upon completion…
Aegon (ENXTAM:AGN) stays in focus after investors reviewed fresh return data alongside its broad insurance footprint across the Americas, the Netherlands, the United Kingdom and other markets, putting recent share performance under closer scrutiny.
Aegon has delivered a powerful 5 year run, yet the recent pullback leaves a clear question on the table for investors who care about what they are paying for each euro of earnings.
Aegon (NYSE:AEG) shareholders approved a proposal to re-domicile the insurer to the United States, where the company plans to operate as Transamerica Inc. The extraordinary general meeting also approved an omnibus equity incentive plan scheduled to take…
Schiphol, October 8, 2026 - Aegon Ltd.’s Extraordinary General Meeting of Shareholders (EGM) today approved both the Redomiciliation and the Omnibus Incentive Plan proposal, giving Aegon the mandate to proceed with its redomiciliation to the US.
Schiphol, October 8, 2026 - Aegon Ltd.’s Extraordinary General Meeting of Shareholders (EGM) today approved both the Redomiciliation and the Omnibus Incentive Plan proposal, giving Aegon the mandate to proceed with its redomiciliation to the US.
Aegon (ENXTAM:AGN) has drawn fresh attention after its recent trading session, with the share price closing at €7.83. Investors are weighing this level against the insurer’s recent returns and valuation metrics.
The firm said it had made £210 million worth of cost savings as part of a three-year £250 million cost-cutting target.